메뉴 건너뛰기




Volumn 107, Issue 1-2, 2002, Pages 17-21

Differences between neonates and adults in plasmin inhibitory and antifibrinolytic action of aprotinin

Author keywords

Aprotinin; Fibrinolysis; Neonates; Plasmin

Indexed keywords

ANTIPLASMIN; APROTININ; PLASMIN; PLASMINOGEN; ANTIFIBRINOLYTIC AGENT; HEMOSTATIC AGENT;

EID: 0037101574     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(02)00205-0     Document Type: Article
Times cited : (2)

References (35)
  • 1
    • 0026331304 scopus 로고
    • Basic and clinical aspects of fibrinolysis and thrombolysis
    • Collen D., Lijnen H.R. Basic and clinical aspects of fibrinolysis and thrombolysis. Blood. 78:1991;3114-3124.
    • (1991) Blood , vol.78 , pp. 3114-3124
    • Collen, D.1    Lijnen, H.R.2
  • 2
    • 0029086663 scopus 로고
    • Developmental hemostasis: Relevance to thromboembolic complications in pediatric patients
    • Andrew M. Developmental hemostasis: relevance to thromboembolic complications in pediatric patients. Thromb. Haemost. 74:1995;415-425.
    • (1995) Thromb. Haemost. , vol.74 , pp. 415-425
    • Andrew, M.1
  • 5
    • 0025279780 scopus 로고
    • Neonatal plasminogen displays altered cell surface binding and activation kinetics. Correlation with increased glycosylation of the protein
    • Edelberg J.M., Enghild J.J., Pizzo S.V., Gonzalez-Gronow M. Neonatal plasminogen displays altered cell surface binding and activation kinetics. Correlation with increased glycosylation of the protein. J. Clin. Invest. 86:1990;107-112.
    • (1990) J. Clin. Invest. , vol.86 , pp. 107-112
    • Edelberg, J.M.1    Enghild, J.J.2    Pizzo, S.V.3    Gonzalez-Gronow, M.4
  • 6
    • 0017157407 scopus 로고
    • Evaluation of the role of in vivo proteolysis (fibrinogenolysis) in prolonging the thrombin time of human umbilical cord fibrinogen
    • Galanakis D.K., Mossesson M.W. Evaluation of the role of in vivo proteolysis (fibrinogenolysis) in prolonging the thrombin time of human umbilical cord fibrinogen. Blood. 48:1976;109-118.
    • (1976) Blood , vol.48 , pp. 109-118
    • Galanakis, D.K.1    Mossesson, M.W.2
  • 7
    • 0019976037 scopus 로고
    • Sialic acid and enzymatic desialation of cord blood fibrinogen
    • Francis J.L., Armstrong D.J. Sialic acid and enzymatic desialation of cord blood fibrinogen. Haemostasis. 11:1982;223-228.
    • (1982) Haemostasis , vol.11 , pp. 223-228
    • Francis, J.L.1    Armstrong, D.J.2
  • 8
    • 0000822691 scopus 로고
    • Fetales Fibrinogen
    • Künzer W. Fetales Fibrinogen. Klin. Wochenschr. 39:1961;536-542.
    • (1961) Klin. Wochenschr. , vol.39 , pp. 536-542
    • Künzer, W.1
  • 9
    • 0030812289 scopus 로고    scopus 로고
    • Molecular and functional properties of fetal plasminogen and its possible influence on clot lysis in the neonatal period
    • Ries M. Molecular and functional properties of fetal plasminogen and its possible influence on clot lysis in the neonatal period. Semin. Thromb. Hemost. 23:1997;247-252.
    • (1997) Semin. Thromb. Hemost. , vol.23 , pp. 247-252
    • Ries, M.1
  • 10
    • 0035425338 scopus 로고    scopus 로고
    • Differences between neonates and adults in tissue-type-plasminogen activator (t-PA)-catalyzed plasminogen activation with various effectors and in carbohydrate sequences of fibrinogen chains
    • Ries M., Easton R.L., Longstaff C., Zenker M., Corran P.H., Morris H.R.et al. Differences between neonates and adults in tissue-type-plasminogen activator (t-PA)-catalyzed plasminogen activation with various effectors and in carbohydrate sequences of fibrinogen chains. Thromb. Res. 103:2001;173-184.
    • (2001) Thromb. Res. , vol.103 , pp. 173-184
    • Ries, M.1    Easton, R.L.2    Longstaff, C.3    Zenker, M.4    Corran, P.H.5    Morris, H.R.6
  • 11
    • 0034668795 scopus 로고    scopus 로고
    • Differences between neonates and adults in the urokinase-plasminogen activator (u-PA) pathway of the fibrinolytic system
    • Ries M., Zenker M., Gaffney P.J. Differences between neonates and adults in the urokinase-plasminogen activator (u-PA) pathway of the fibrinolytic system. Thromb. Res. 100:2000;34-51.
    • (2000) Thromb. Res. , vol.100 , pp. 34-51
    • Ries, M.1    Zenker, M.2    Gaffney, P.J.3
  • 12
    • 0024437939 scopus 로고
    • Comparison of human normal, full-term, fetal and adult plasminogen by physical and chemical analyses
    • Summaria L. Comparison of human normal, full-term, fetal and adult plasminogen by physical and chemical analyses. Haemostasis. 19:1989;266-273.
    • (1989) Haemostasis , vol.19 , pp. 266-273
    • Summaria, L.1
  • 13
    • 0014953369 scopus 로고
    • Phosphorus and hexose content of human fetal fibrinogen
    • Witt I., Müller H. Phosphorus and hexose content of human fetal fibrinogen. Biochim. Biophys. Acta. 221:1970;402-404.
    • (1970) Biochim. Biophys. Acta , vol.221 , pp. 402-404
    • Witt, I.1    Müller, H.2
  • 16
    • 0000889152 scopus 로고
    • A comparison of the fibrinolytic enzyme system in maternal and umbilical-cord blood
    • Phillips L.L., Skrodelis V. A comparison of the fibrinolytic enzyme system in maternal and umbilical-cord blood. Pediatrics. 22:1958;715-726.
    • (1958) Pediatrics , vol.22 , pp. 715-726
    • Phillips, L.L.1    Skrodelis, V.2
  • 17
    • 0029142941 scopus 로고
    • Age related differences in a clot lysis assay after adding different plasminogen activators in a plasma milieu in vitro
    • Ries M., Zenker M., Klinge J., Keuper H., Harms D. Age related differences in a clot lysis assay after adding different plasminogen activators in a plasma milieu in vitro. J. Pediatr. Hematol./Oncol. 17:1995;260-264.
    • (1995) J. Pediatr. Hematol./Oncol. , vol.17 , pp. 260-264
    • Ries, M.1    Zenker, M.2    Klinge, J.3    Keuper, H.4    Harms, D.5
  • 18
    • 0029911411 scopus 로고    scopus 로고
    • In vitro fibrinolysis after adding low doses of plasminogen activators and plasmin generation with and without oxidative inactivation of plasmin inhibitors in newborns and adults
    • Ries M., Klinge J., Rauch R., Trusen B., Zenker M., Keuper H.et al. In vitro fibrinolysis after adding low doses of plasminogen activators and plasmin generation with and without oxidative inactivation of plasmin inhibitors in newborns and adults. J. Pediatr. Hematol./Oncol. 18:1996;346-351.
    • (1996) J. Pediatr. Hematol./Oncol. , vol.18 , pp. 346-351
    • Ries, M.1    Klinge, J.2    Rauch, R.3    Trusen, B.4    Zenker, M.5    Keuper, H.6
  • 19
    • 0014216684 scopus 로고
    • The peptide chains of human plasmin. Mechanism of activation of human plasminogen to plasmin
    • Robbins K.C., Summaria L., Hsieh B., Shah R.J. The peptide chains of human plasmin. Mechanism of activation of human plasminogen to plasmin. J. Biol. Chem. 242:1967;2333-2342.
    • (1967) J. Biol. Chem. , vol.242 , pp. 2333-2342
    • Robbins, K.C.1    Summaria, L.2    Hsieh, B.3    Shah, R.J.4
  • 21
    • 0027991616 scopus 로고
    • Studies on the mechanism of action of aprotinin and tranexamic acid as plasmin inhibitors and antifibrinolytic agents
    • Longstaff C. Studies on the mechanism of action of aprotinin and tranexamic acid as plasmin inhibitors and antifibrinolytic agents. Blood Coagul. Fibrinolysis. 5:1994;537-542.
    • (1994) Blood Coagul. Fibrinolysis , vol.5 , pp. 537-542
    • Longstaff, C.1
  • 23
    • 0014932863 scopus 로고
    • Plasminogen: Purification from human plasma by affinity chromatography
    • Deutsch D.G., Mertz E.T. Plasminogen: purification from human plasma by affinity chromatography. Science. 170:1970;1095-1096.
    • (1970) Science , vol.170 , pp. 1095-1096
    • Deutsch, D.G.1    Mertz, E.T.2
  • 24
    • 0015373803 scopus 로고
    • Measurement of the binding of antifibrinolytic amino acids to various plasminogens
    • Brockway W.J., Castellino F.J. Measurement of the binding of antifibrinolytic amino acids to various plasminogens. Arch. Biochem. Biophys. 151:1972;194-199.
    • (1972) Arch. Biochem. Biophys. , vol.151 , pp. 194-199
    • Brockway, W.J.1    Castellino, F.J.2
  • 25
    • 0015546107 scopus 로고
    • Determination of the operational molarity of solutions of bovine alpha-chymotrypsin, trypsin, thrombin and factor Xa by spectrofluorimetric titration
    • Jameson G.W., Roberts D.V., Adams R.W.A., Kyle W.S.A., Elmore D.T. Determination of the operational molarity of solutions of bovine alpha-chymotrypsin, trypsin, thrombin and factor Xa by spectrofluorimetric titration. Biochem. J. 131:1973;107-117.
    • (1973) Biochem. J. , vol.131 , pp. 107-117
    • Jameson, G.W.1    Roberts, D.V.2    Adams, R.W.A.3    Kyle, W.S.A.4    Elmore, D.T.5
  • 26
    • 0018679842 scopus 로고
    • Carbohydrate of the human plasminogen variants: I. Carbohydrate composition, glycopeptide isolation, and characterization
    • Hayes M.L., Castellino F.J. Carbohydrate of the human plasminogen variants: I. Carbohydrate composition, glycopeptide isolation, and characterization. J. Biol. Chem. 254:1979;8768-8771.
    • (1979) J. Biol. Chem. , vol.254 , pp. 8768-8771
    • Hayes, M.L.1    Castellino, F.J.2
  • 27
    • 0018724413 scopus 로고
    • Carbohydrate of the human plasminogen variants: II. Structure of the asparagine-linked oligosaccharide unit
    • Hayes M.L., Castellino F.J. Carbohydrate of the human plasminogen variants: II. Structure of the asparagine-linked oligosaccharide unit. J. Biol. Chem. 254:1979;8772-8776.
    • (1979) J. Biol. Chem. , vol.254 , pp. 8772-8776
    • Hayes, M.L.1    Castellino, F.J.2
  • 28
    • 0018670737 scopus 로고
    • Carbohydrate of the human plasminogen variants: III. Structure of the O-glycosidically linked oligosaccharide unit
    • Hayes M.L., Castellino F.J. Carbohydrate of the human plasminogen variants: III. Structure of the O-glycosidically linked oligosaccharide unit. J. Biol. Chem. 254:1979;8777-8780.
    • (1979) J. Biol. Chem. , vol.254 , pp. 8777-8780
    • Hayes, M.L.1    Castellino, F.J.2
  • 29
    • 0030972010 scopus 로고    scopus 로고
    • Evidence for a novel O-linked sialylated trisaccharide on Ser-248 of human plasminogen 2
    • Pirie-Shepherd S.R., Stevens R.D., Andon N.L., Enghild J.J., Pizzo S.V. Evidence for a novel O-linked sialylated trisaccharide on Ser-248 of human plasminogen 2. J. Biol. Chem. 272:1997;7408-7411.
    • (1997) J. Biol. Chem. , vol.272 , pp. 7408-7411
    • Pirie-Shepherd, S.R.1    Stevens, R.D.2    Andon, N.L.3    Enghild, J.J.4    Pizzo, S.V.5
  • 31
    • 0018154871 scopus 로고
    • On the kinetics of the reaction between human antiplasmin and a low-molecular-weight form of plasmin
    • Wiman B., Boman L., Collen D. On the kinetics of the reaction between human antiplasmin and a low-molecular-weight form of plasmin. Eur. J. Biochem. 87:1978;143-146.
    • (1978) Eur. J. Biochem. , vol.87 , pp. 143-146
    • Wiman, B.1    Boman, L.2    Collen, D.3
  • 32
    • 0342953146 scopus 로고    scopus 로고
    • Activation of hemostasis during cardiopulmonary bypass and pediatric aprotinin dosage
    • Mossinger H., Dietrich W. Activation of hemostasis during cardiopulmonary bypass and pediatric aprotinin dosage. Ann. Thorac. Surg. 65:1998;S45-S50.
    • (1998) Ann. Thorac. Surg. , vol.65
    • Mossinger, H.1    Dietrich, W.2
  • 33
    • 0033009619 scopus 로고    scopus 로고
    • Aprotinin: An update of its pharmacology and therapeutic use in open heart surgery and coronary artery bypass surgery
    • Peters D.C., Noble S. Aprotinin: an update of its pharmacology and therapeutic use in open heart surgery and coronary artery bypass surgery. Drugs. 57:1999;233-260.
    • (1999) Drugs , vol.57 , pp. 233-260
    • Peters, D.C.1    Noble, S.2
  • 34
    • 0032443031 scopus 로고    scopus 로고
    • The efficacy and safety of aprotinin use in cardiac surgery
    • Rich J.B. The efficacy and safety of aprotinin use in cardiac surgery. Ann. Thorac. Surg. 66:1998;S6-S11.
    • (1998) Ann. Thorac. Surg. , vol.66
    • Rich, J.B.1
  • 35
    • 0031831248 scopus 로고    scopus 로고
    • Use of aprotinin in pediatric organ transplantation
    • Spray T.L. Use of aprotinin in pediatric organ transplantation. Ann. Thorac. Surg. 65:1998;S71-S73.
    • (1998) Ann. Thorac. Surg. , vol.65
    • Spray, T.L.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.